Literature DB >> 17267639

Hetero-vancomycin-intermediate methicillin-resistant Staphylococcus aureus isolate from a medical center in Las Cruces, New Mexico.

Alejandro Delgado1, James T Riordan, Reena Lamichhane-Khadka, David C Winnett, Jennifer Jimenez, Kim Robinson, Frances G O'Brien, Stephanie A Cantore, John E Gustafson.   

Abstract

A survey of 152 methicillin-resistant Staphylococcus aureus (MRSA) strains from medical centers in Las Cruces, NM, and El Paso, TX, revealed the presence of spa types 2 and 24 (clone USA100) and spa type 1 (clone USA300-0114). Las Cruces MRSA displayed relatively high vancomycin MICs, and one hetero-vancomycin-intermediate S. aureus strain was identified.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17267639      PMCID： PMC1865829          DOI： 10.1128/JCM.02437-06

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  17 in total

1.  The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

Authors:  K Sieradzki; R B Roberts; S W Haber; A Tomasz
Journal:  N Engl J Med       Date:  1999-02-18       Impact factor: 91.245

2.  Methicillin-resistant S. aureus infections among patients in the emergency department.

Authors:  Gregory J Moran; Anusha Krishnadasan; Rachel J Gorwitz; Gregory E Fosheim; Linda K McDougal; Roberta B Carey; David A Talan
Journal:  N Engl J Med       Date:  2006-08-17       Impact factor: 91.245

3.  The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Mark C Enright; D Ashley Robinson; Gaynor Randle; Edward J Feil; Hajo Grundmann; Brian G Spratt
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  Effects of sarA inactivation on the intrinsic multidrug resistance mechanism of Staphylococcus aureus.

Authors:  Jessica O O'Leary; Mark J Langevin; Christopher T D Price; Jon S Blevins; Mark S Smeltzer; John E Gustafson
Journal:  FEMS Microbiol Lett       Date:  2004-08-15       Impact factor: 2.742

5.  Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus.

Authors:  Patrick G P Charles; Peter B Ward; Paul D R Johnson; Benjamin P Howden; M Lindsay Grayson
Journal:  Clin Infect Dis       Date:  2004-01-12       Impact factor: 9.079

6.  spa typing method for discriminating among Staphylococcus aureus isolates: implications for use of a single marker to detect genetic micro- and macrovariation.

Authors:  Larry Koreen; Srinivas V Ramaswamy; Edward A Graviss; Steven Naidich; James M Musser; Barry N Kreiswirth
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

7.  Endocarditis caused by Staphylococcus aureus with reduced susceptibility to vancomycin.

Authors:  Christopher W Woods; Allen C Cheng; Vance G Fowler; Mary Moorefield; Joyce Frederick; George Sakoulas; Venkata G Meka; Fred C Tenover; Peter Zwadyk; Kenneth H Wilson
Journal:  Clin Infect Dis       Date:  2004-04-05       Impact factor: 9.079

8.  Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database.

Authors:  Linda K McDougal; Christine D Steward; George E Killgore; Jasmine M Chaitram; Sigrid K McAllister; Fred C Tenover
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

9.  Molecular epidemiology of methicillin-resistant Staphylococcus aureus in 12 New York hospitals. MRSA Collaborative Study Group.

Authors:  R B Roberts; A de Lencastre; W Eisner; E P Severina; B Shopsin; B N Kreiswirth; A Tomasz
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

10.  Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001.

Authors:  Scott K Fridkin; Jeff Hageman; Linda K McDougal; Jasmine Mohammed; William R Jarvis; Trish M Perl; Fred C Tenover
Journal:  Clin Infect Dis       Date:  2003-01-31       Impact factor: 9.079
View more
  19 in total

Review 1.  Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates.

Authors:  Sebastiaan J van Hal; David L Paterson
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

2.  Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center.

Authors:  Klaudia Kosowska-Shick; Lois M Ednie; Pamela McGhee; Kathy Smith; Cynthia D Todd; Amanda Wehler; Peter C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

3.  Tea tree oil-induced transcriptional alterations in Staphylococcus aureus.

Authors:  Jesus A Cuaron; Santosh Dulal; Yang Song; Atul K Singh; Cesar E Montelongo; Wanqin Yu; Vijayaraj Nagarajan; Radheshyam K Jayaswal; Brian J Wilkinson; John E Gustafson
Journal:  Phytother Res       Date:  2012-05-23       Impact factor: 5.878

4.  The use of laser-induced breakdown spectroscopy for distinguishing between bacterial pathogen species and strains.

Authors:  Rosalie A Multari; David A Cremers; Joanne M Dupre; John E Gustafson
Journal:  Appl Spectrosc       Date:  2010-07       Impact factor: 2.388

5.  GenHtr: a tool for comparative assessment of genetic heterogeneity in microbial genomes generated by massive short-read sequencing.

Authors:  Gongxin Yu
Journal:  BMC Bioinformatics       Date:  2010-10-12       Impact factor: 3.169

6.  An exploratory study of methicillin-resistant Staphylococcus aureus and SCCmec elements obtained from a community setting along the Texas border with Mexico.

Authors:  David R Ammons; Raghuveer Puttagunta; Jose C Granados; Georgina de la Garza; George S Eyambe; Joanne Rampersad
Journal:  Curr Microbiol       Date:  2009-11-24       Impact factor: 2.188

7.  Combinations of cefoxitin plus other β-lactams are synergistic in vitro against community associated methicillin-resistant Staphylococcus aureus.

Authors:  R Banerjee; M G Fernandez; N Enthaler; C Graml; K E Greenwood-Quaintance; R Patel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-01-23       Impact factor: 3.267

8.  Isolation and characterization of Staphylococcus aureus strains from a Paso del Norte dairy.

Authors:  S A Matyi; J M Dupre; W L Johnson; P R Hoyt; D G White; T Brody; W F Odenwald; J E Gustafson
Journal:  J Dairy Sci       Date:  2013-04-19       Impact factor: 4.034

9.  sarA inactivation reduces vancomycin-intermediate and ciprofloxacin resistance expression by Staphylococcus aureus.

Authors:  Reena Lamichhane-Khadka; Stephanie A Cantore; James T Riordan; Alejandro Delgado; Alesha E A Norman; Sarah Dueñas; Shahrear Zaman; Sonia Horan; Brian J Wilkinson; John E Gustafson
Journal:  Int J Antimicrob Agents       Date:  2009-03-25       Impact factor: 5.283

Review 10.  Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications.

Authors:  Benjamin P Howden; John K Davies; Paul D R Johnson; Timothy P Stinear; M Lindsay Grayson
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.